New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not safe.

It’s a sticky business. Scientists have uncovered how embryos stick to the uterus in the first week of life. The discovery might one day help improve treatments for recurrent miscarriages and ...

Human eggs that contain too many or too few chromosomes can lead to miscarriage, IVF failure and conditions such as Down’s syndrome. Now, researchers have found ...

Scientists are seeking permission to generate human embryonic stem cells to study disease by introducing human genetic material into an animal oocyte. This has raised ethical questions that centre on ...

Embryonic stem cells (ESCs) are stem cells derived from the undifferentiated inner mass cells of a human embryo. Embryonic stem cells are pluripotent, meaning they are able to grow (i.e. differentiate ...

Jérôme Dupras is a member of one of Quebec’s most popular folk rock bands. Now, as the province’s chief scientist, he will ...

Alan Murray, Co-founder and CEO, Conceivable Life Sciences - is an engineer and serial entrepreneur with more than three decades of experience spanning technology, machine learning, hardware, ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Exposure to secondhand cigarette smoke during the first days of life can cause changes in tooth enamel mineralization without ...

It belatedly emerged that a 6-year-old girl in China who had a rare genetic disease died a week after receiving the world's first brain gene-editing treatment. The researchers released animal test ...

Until recently, the idea of cloning a Neanderthal seemed exclusively a science fiction plot. However, today such issues are increasingly being discussed seriously, not only due to the rapid ...

A six-year-old girl's death in China highlights the urgent need for regulation in gene-editing trials amid ethical concerns.